Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
mastodynia/illamående
Länken sparas på Urklipp
Sida 1 från 43 resultat
Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To compare the effectiveness and side effects of cabergoline with bromocriptine for the symptomatic treatment of cyclic mastalgia as a part of the premenstrual syndrome.
METHODS
140 women with premenstrual mastalgia were enrolled in this randomised, open-label trial. Two groups were
Pilot study on the treatment of cyclical mastodynia with Quinagolide.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
In a pilot clinical trial on 52 patients, 75 microg Quinagolide given once per day was administered for the treatment of cyclical mastodynia. Linear analogue charts were used for the assessment of response. Decrease in breast pain, heaviness, tenderness and serum prolactin level on the one hand, and
Clinical Factors Affecting the Therapeutic Efficacy of Evening Primrose Oil on Mastalgia
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Background: Saturated fatty acid esters may cause mastalgia via hypersensitivity of breast epithelium to circulating hormones. Evening primrose oil (EPO) may restore the saturated/unsaturated fatty acid balance and decrease sensitivity to
European multicentre trial of bromocriptine in cyclical mastalgia.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
In a randomised parallel-block trial in thirteen European centres bromocriptine 2.5 mg twice a day was compared with placebo therapy for cyclical mastalgia. 272 patients were enrolled into the study. Linear analogue charts and diary pain cards were used for assessment of response. Reduction in
[Danazol effectivity in control of moderate to severe mastalgia].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Ten percent of women present with moderate to severe mastalgia, and danazol achieves pain relief control with variable results. The objective of this study was to know the success of danazol to control moderate to severe mastalgia.
METHODS
A descriptive, open, transversal and
Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
The objective of this study was to compare bleeding patterns of women using a contraceptive combination of 30 mcg ethinylestradiol (EE) and 3 mg drospirenone (DRSP) continuously or cyclically. Menstrual-related symptoms were also evaluated.
METHODS
This open, prospective, randomized study
[Misoprostol in substitution at uterine curettage in early pregnancy failure].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To evaluate the effectiveness of misoprostol administered vaginally for uterine evacuation in interrupted early pregnancies and the time between the administration and emptying correlated with gestational age.
METHODS
Clinical trial with 41 patients with pregnancies interrupted between the
Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
This multicenter, open-label study was conducted to compare the cycle control, efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive containing gestodene (GTD) 60 microg/ethinylestradiol (EE) 15 microg and a 21-day regimen of desogestrel (DSG) 150 microg/EE 20
The efficacy and tolerability of Valette: a postmarketing surveillance study.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
A postmarketing survey was carried out to determine the efficacy and tolerability of Valette (dienogest 2.0 mg and ethinylestradiol 0.03 mg) in routine gynecological practice.
RESULTS
Valette had excellent contraceptive efficacy (unadjusted Pearl index 0.14), with 11 unplanned pregnancies
Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Changes in body weight and the incidence of estrogen-related side effects with low-dose oral contraceptives (OCs) containing 20 microg ethinyl estradiol (EE) have not been demonstrated in placebo-controlled trials. Two placebo-controlled, randomized trials demonstrated the efficacy of a low-dose OC
Clinical experience with a new norgestimate-containing oral contraceptive.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Research in the area of oral contraception currently focuses on the development of selective progestogens that combine targeted progestational and antiovulatory activity with a minimal potential for androgenicity. The present dual-center study was conducted to investigate the efficacy, tolerability,
Clinical experience with a new norgestimate-containing oral contraceptive.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Research in the area of oral contraception currently focuses on the development of selective progestogens that combine targeted progestational and antiovulatory activity with a minimal potential for androgenicity. The present dual-center study was conducted to investigate the efficacy, tolerability,
Effects of a Hypnosis Session Before General Anesthesia on Postoperative Outcomes in Patients Who Underwent Minor Breast Cancer Surgery: The HYPNOSEIN Randomized Clinical Trial.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Hormonal treatment for prostate cancer in Italy. Preliminary data from a survey of the QUABIOS Group.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
An observational study was planned by the QUABIOS group, to survey the hormonal modalities administered to prostate cancer patients in Italy within a time window of 12 months. We report here a summary of treatment schedules and related adverse effects, as recorded at the first
Interception II: postcoital low-dose estrogens and norgestrel combination in 633 women.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The new low-dose hormonal postcoital method, a combination of 200 mcg ethinylestradiol and 2 mg norgestrel was used in 633 women, and a statistically significantly lower observed pregnancy rate was found compared to the expected number of pregnancies if no contraception was used. Patterns of
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
